![](/img/cover-not-exists.png)
PD10-10 A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL EVALUATING OVERALL SURVIVAL IN PATIENTS WITH PRIMARY BONE METASTATIC PROSTATE CANCER (MPCA) RECEIVING EITHER ANDROGEN DEPRIVATION THERAPY (ADT) OR ADT COMBINED WITH CONCURRENT RADIATION THERAPY TO THE PROSTATE, FINAL DATA FROM THE HORRAD TRIAL
Boevé, Liselotte, Hulshof, Maarten, Vis, André, Zwinderman, Koos, Twisk, Jos, Delaere, Karl, van Moorselaar, Jeroen, Verhagen, Paul, van Andel, GeorgeVolume:
199
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2018.02.620
Date:
April, 2018
File:
PDF, 309 KB
english, 2018